Internal Medicine, Endocrinology, Diabetes, & Metabolism · Dartmouth, MA
NPI
1376738039
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
535 Faunce Corner Rd
Dartmouth, MA, 02747
Phone (508) 996-3991
Groups this clinician bills Medicare through
Medicare paid, 2024
$165K
5,688 services
Medicare patients, 2024
474
Average age 71
Drug cost, 2024
$2.7M
5,765 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna Kozupa was code J0897 (injection, denosumab, 1 mg), 2,641 times for 33 patients. In total Anna Kozupa billed 5,688 services in 65 codes, and Medicare paid $165K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-02-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,641 | 33 | $20.62 | $54K |
| 99214 Office E&M - Established | Office | 571 | 303 | $94.50 | $54K |
| 99213 Office E&M - Established | Office | 377 | 259 | $66.34 | $25K |
| 82962 Clinical Chemistry | Office | 311 | 162 | $3.21 | $998 |
| 36415 Venipuncture Blood Collection | Office | 307 | 229 | $8.65 | $2,656 |
| 84443 Clinical Chemistry | Office | 159 | 125 | $16.46 | $2,617 |
| 83036 Blood Count | Office | 139 | 134 | $9.45 | $1,314 |
| 80053 Clinical Chemistry | Office | 132 | 123 | $10.27 | $1,356 |
| 99441 Telephone Services | Office | 131 | 80 | $44.15 | $5,783 |
| 96372 Injection Administration | Office | 100 | 48 | $9.88 | $988 |
| 80061 Clinical Chemistry | Office | 93 | 89 | $12.98 | $1,207 |
| 83735 Clinical Chemistry | Office | 66 | 59 | $6.57 | $434 |
| 82570 Clinical Chemistry | Office | 57 | 55 | $4.99 | $284 |
| 82043 Clinical Chemistry | Office | 53 | 52 | $5.55 | $294 |
| 82607 Clinical Chemistry | Office | 52 | 48 | $14.78 | $769 |
By year: 2022 $187K for 9,136 services; 2023 $212K for 10,539 services; 2024 $165K for 5,688 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 311 | 162 | $3.21 | $998 |
| 36415 Venipuncture Blood Collection | 307 | 229 | $8.65 | $2,656 |
| 84443 Clinical Chemistry | 159 | 125 | $16.46 | $2,617 |
| 83036 Blood Count | 139 | 134 | $9.45 | $1,314 |
| 80053 Clinical Chemistry | 132 | 123 | $10.27 | $1,356 |
| 80061 Clinical Chemistry | 93 | 89 | $12.98 | $1,207 |
| 83735 Clinical Chemistry | 66 | 59 | $6.57 | $434 |
| 82570 Clinical Chemistry | 57 | 55 | $4.99 | $284 |
| 82043 Clinical Chemistry | 53 | 52 | $5.55 | $294 |
| 82607 Clinical Chemistry | 52 | 48 | $14.78 | $769 |
Medicare prescription drug claims, 2024
In 2024, the drug Anna Kozupa prescribed most often to Medicare patients was Ozempic (Semaglutide), with 524 prescriptions and refills. In total Anna Kozupa wrote 5,765 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 524 | 729 | 90 | $662K |
| Levothyroxine Sodium Generic | 513 | 1,261 | 129 | $7,987 |
| Jardiance Empagliflozin | 413 | 762 | 93 | $431K |
| Metformin Hcl Generic | 243 | 640 | 77 | $3,115 |
| Metformin Hcl Er Metformin Hcl | 233 | 624 | 68 | $3,697 |
| Mounjaro Tirzepatide | 185 | 211 | 33 | $225K |
| Farxiga Dapagliflozin Propanediol | 166 | 315 | 42 | $170K |
| Alendronate Sodium Generic | 158 | 371 | 44 | $1,109 |
| Glipizide Er Glipizide | 157 | 409 | 45 | $3,090 |
| Synthroid Levothyroxine Sodium | 148 | 331 | 33 | $14K |
| Tresiba Flextouch U-100 Insulin Degludec | 134 | 250 | 30 | $65K |
| Pioglitazone Hcl Generic | 134 | 298 | 36 | $1,767 |
| Januvia Sitagliptin Phosphate | 109 | 215 | 22 | $113K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 100 | 267 | 40 | $8,763 |
| Repaglinide Generic | 99 | 216 | 25 | $3,590 |
Brand drugs: 3,011 claims; generic drugs: 2,401 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Anna Kozupa were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.